BIOMAT Database Logo BIOMAT Database Logo

[Fatal sub-fulminant hepatitis caused by cyproterone acetate. A new case]. 1996

P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund

UI MeSH Term Description Entries
D008297 Male Males
D006501 Hepatic Encephalopathy A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) Encephalopathy, Hepatic,Portosystemic Encephalopathy,Encephalopathy, Hepatocerebral,Encephalopathy, Portal-Systemic,Encephalopathy, Portosystemic,Fulminant Hepatic Failure with Cerebral Edema,Hepatic Coma,Hepatic Stupor,Hepatocerebral Encephalopathy,Portal-Systemic Encephalopathy,Coma, Hepatic,Comas, Hepatic,Encephalopathies, Hepatic,Encephalopathies, Hepatocerebral,Encephalopathies, Portal-Systemic,Encephalopathies, Portosystemic,Encephalopathy, Portal Systemic,Hepatic Comas,Hepatic Encephalopathies,Hepatic Stupors,Hepatocerebral Encephalopathies,Portal Systemic Encephalopathy,Portal-Systemic Encephalopathies,Portosystemic Encephalopathies,Stupor, Hepatic,Stupors, Hepatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D017373 Cyproterone Acetate An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites. Androcur,Cyproterone Acetate, (1 alpha,2 alpha)-Isomer,Cyproterone Acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer,Cyproterone Acetate, (17 alpha)-Isomer
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund
Fatal fulminant hepatitis from cyproterone acetate.
March 1994, Israel journal of medical sciences,
P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund
[Fatal hepatitis caused by cyproterone acetate].
January 1994, Therapie,
P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund
[Fatal subfulminant hepatitis caused by cyproterone acetate].
January 1991, Gastroenterologie clinique et biologique,
P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund
Fatal fulminant hepatitis in a chimpanzee (Pan troglodytes) receiving cyproterone acetate.
December 2009, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,
P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund
Fulminant hepatitis due to cyproterone acetate.
January 1989, Lancet (London, England),
P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund
Severe hepatitis caused by cyproterone acetate.
May 1990, Gut,
P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund
Fatal fulminant hepatic failure due to cyproterone acetate.
July 1999, Digestive diseases and sciences,
P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund
Fatal acute liver failure induced by cyproterone acetate: A new case.
December 2017, Presse medicale (Paris, France : 1983),
P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund
Fatal fulminant hepatitis in a patient taking abiraterone acetate: a case report.
January 2023, Frontiers in medicine,
P Castellani, and D Bernardini, and C Renou, and C Zamora, and I Portal, and A Gauthier, and D Botta-Fridlund
Fulminant liver failure caused by cyproterone.
September 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
Copied contents to your clipboard!